Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BerGenBio ASA ( (BRRGF) ) just unveiled an update.
Oncoinvent ASA has completed a fully underwritten rights issue, resulting in the allocation of 260,000,000 new shares to various primary insiders and their close associates. This significant capital raise is contingent upon approval at an extraordinary general meeting and is subject to regulatory disclosure requirements.
The most recent analyst rating on (BRRGF) stock is a Buy with a NOK38.00 price target. To see the full list of analyst forecasts on BerGenBio ASA stock, see the BRRGF Stock Forecast page.
More about BerGenBio ASA
Average Trading Volume: 443,119
Current Market Cap: NOK208.3M
For an in-depth examination of BRRGF stock, go to TipRanks’ Overview page.